View Older Stories View More Recent Stories

Nov 1, 2017 03:00AM Aegon Completes Sale of Unirobe Meeùs Groep
Oct 26, 2017 07:01AM CoolSculpting® Breaks the Ice about Non-Invasive Fat Freezing with Actress Debra Messing
Sep 28, 2017 11:51AM Aegon Announces Repurchase of Shares to Neutralize 2016 Final and 2017 Interim Stock Dividends
Sep 14, 2017 02:57PM Amgen (AMGN), Allergan (AGN) Confirm FDA Approval of MVASI For Treatment of Five Types of Cancer
Sep 14, 2017 02:54PM FDA Approves Amgen And Allergan's MVASI™ (bevacizumab-awwb) For The Treatment Of Five Types Of Cancer
Sep 13, 2017 02:00AM Aegon Announces Stock Fraction Interim Dividend 2017
Sep 11, 2017 05:46AM Amgen (AMGN) & Allergen (AGN) Report Phase 3 Data On Biosimilar Trastuzumab Candidate ABP 980
Sep 9, 2017 03:00AM Amgen And Allergan Present Phase 3 Data On Biosimilar Trastuzumab Candidate ABP 980 At The European Society For Medical Oncology 2017 Congress
Aug 10, 2017 01:00AM Aegon to Divest Its Business in Ireland
Aug 8, 2017 02:00AM Aegon to Sell Unirobe Meeùs Groep
Jul 31, 2017 09:03AM Amgen (AMGN) & Allergan (AGN) Report U.S. FDA Submission of Biosimilar Biologics License Application For ABP 980
Jul 31, 2017 09:00AM Amgen And Allergan Submit Biosimilar Biologics License Application For ABP 980 To US Food And Drug Administration
Jul 27, 2017 06:30AM Nielsen Reports 2nd Quarter 2017 Results
Jul 19, 2017 10:41AM Global economy suffers $53bn natural disaster loss during 1H 2017, according to Aon catastrophe report
Jul 18, 2017 03:30PM Ward Group Reveals Its Ward's 50 List of Top Performing Insurance Companies for 2017
Jul 14, 2017 04:30PM Aon Declares Quarterly Dividend
Jul 13, 2017 08:06AM Amgen (AMGN), Allergan (AGN) to Discuss Data Supporting BLA For ABP 215 with FDA
Jul 13, 2017 08:00AM Amgen And Allergan To Discuss Data Supporting Biologics License Application For ABP 215, A Biosimilar Candidate To Avastin® (bevacizumab)
Jul 12, 2017 04:30PM Aon Announces Second Quarter 2017 Earnings Release and Conference Call
Jul 6, 2017 12:24PM Flood and convective storm events cost global economy more than $5bn in June, according to Aon catastrophe report
Jun 29, 2017 02:00AM Aegon Completes Sale of Majority of US Run-Off Businesses
Jun 20, 2017 11:45AM Aegon Announces Stock Fraction Final Dividend 2016
Jun 7, 2017 09:01AM Amgen (AMGN) & Allergan (AGN) Reports FDA Advisory Committee Meeting To Review ABP 215 (Biosimilar Candidate To Bevacizumab)
Jun 7, 2017 09:00AM Amgen And Allergan Announce FDA Advisory Committee Meeting To Review ABP 215, A Biosimilar Candidate To Bevacizumab
May 24, 2017 01:00PM Aegon Appoints Global Head of Government and Policy Affairs
May 22, 2017 01:30AM Aegon to Divest Majority of US Run-Off Businesses
May 19, 2017 09:10AM Annual Meeting of Shareholders Adopts All Resolutions
May 16, 2017 07:45AM Allergan's Eyepowerment™ Campaign Releases Survey Revealing the Importance of Eye Language and the Crucial Role it Plays in Our Communications
May 8, 2017 07:03AM Veeva OpenData Reaches 100th Customer Milestone
Apr 13, 2017 09:00AM Allergan and Ironwood Launch Campaign Designed to Empower the Nearly 64 Million Americans Estimated to Suffer from IBS and CIC to Talk About Bowel Health(1-5)
Apr 7, 2017 02:00AM Aegon Publishes Agenda for 2017 Annual General Meeting
Mar 24, 2017 03:00AM Aegon Publishes 2016 Annual Report and Review
Feb 27, 2017 07:30AM Allergan's New Eyepowerment™ Campaign Urges The Up To 33 Million Americans Suffering from Symptoms of Chronic Dry Eye to Take Action
Feb 22, 2017 08:01AM Allergan to Sponsor Alzheimer's Foundation of America '15th Anniversary National Educating America' Tour
Feb 17, 2017 08:56AM Aegon Responds to Inaccurate Information
Feb 8, 2017 07:28AM S&P 500 ekes out gain while banks drag on Dow
Jan 26, 2017 07:13AM Ironwood Pharmaceuticals (IRWD), Allergan (AGN) Gains FDA Approval for 72 mcg Dose of LINZESS
Jan 26, 2017 07:01AM U.S. Food and Drug Administration Approves 72 mcg Dose of LINZESS® (linaclotide) for Adults with Chronic Idiopathic Constipation
Jan 23, 2017 02:03PM Endo Int'l (ENDP) Agrees to Abandon Noncompetitive Pay-for-Delay in Settlement with FTC
Dec 22, 2016 07:03AM Ironwood (IRWD), Allergan (AGN) Announce Phase IIb Data for Linaclotide Colonic Release-1 (CR1) in IBS-C; Plan to Advance to Phase III
Dec 22, 2016 07:00AM Ironwood and Allergan Report Topline Phase IIb Data Supporting Further Investigation of Linaclotide Colonic Release-2 (CR2) for Abdominal Pain in Non-Constipation Subtypes of IBS
Dec 22, 2016 07:00AM Ironwood and Allergan Report Topline Phase IIb Data Supporting Advancement of Linaclotide Colonic Release-1 (CR1) in IBS-C
Dec 15, 2016 07:33AM Aegon Announces Management Changes
Dec 8, 2016 07:00AM Aegon Accelerates Execution of Strategy and Increases Expense Savings
Dec 2, 2016 09:01AM Amgen (AMGN), Allergan (AGN) Announce Submission of ABP 215 MAA to EMA
Dec 2, 2016 09:00AM Amgen And Allergan Submit Biosimilar Marketing Authorization Application To European Medicines Agency For ABP 215, A Biosimilar Candidate To Bevacizumab
Nov 28, 2016 11:00AM Aegon to Appoint Matthew Rider as CFO
Nov 15, 2016 04:01PM Amgen (AMGN) , Allergan (AGN) Submit Biosimilar BLA for ABP 215
Nov 15, 2016 04:00PM Amgen And Allergan Submit Biosimilar Biologics License Application For ABP 215 To U.S. Food And Drug Administration
Oct 3, 2016 02:00AM Aegon Announces Repurchase of Shares to Neutralize 2016 Interim Stock Dividend
View More Recent Stories View Older Stories